Ownership

Jack A. Khattar - President, CEO, Director at Supernus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: President, CEO, Director
Stock Symbol: SUPN on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Jack A. Khattar - trading volume in the past year for Supernus Pharmaceuticals, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-250K	100%	$36.49	-$9.12M
Net	-250K	-100%		-$9.12M

Holdings reported by Jack A. Khattar for Supernus Pharmaceuticals, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	1.01M	$32.3M	$32.06	Apr 2, 2025	Direct
Common Stock	1.01M	$32.2M	$32.06	Apr 2, 2025	By the KBT Trust
Performance Share Unit	0	$0	$32.06	Mar 10, 2025	Direct	Common Stock
Performance Share Units	0	$0	$39.11	Mar 7, 2025	Direct	Common Stock
Employee Stock Option (Right to Buy)	332K			Feb 20, 2025	Direct	Common Stock

Transactions reported by Jack A. Khattar for Supernus Pharmaceuticals, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.